272 related articles for article (PubMed ID: 17059690)
1. Mechanisms of endotoxin neutralization by synthetic cationic compounds.
Andrä J; Gutsmann T; Garidel P; Brandenburg K
J Endotoxin Res; 2006; 12(5):261-77. PubMed ID: 17059690
[TBL] [Abstract][Full Text] [Related]
2. [Advances in the development of neutralizing therapies for sepsis].
Florencia Henning M; Garda H; Bakás L
Medicina (B Aires); 2006; 66(3):263-73. PubMed ID: 16871917
[TBL] [Abstract][Full Text] [Related]
3. Targeting bacterial endotoxin: two sides of a coin.
Bosshart H; Heinzelmann M
Ann N Y Acad Sci; 2007 Jan; 1096():1-17. PubMed ID: 17405910
[TBL] [Abstract][Full Text] [Related]
4. Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide.
Andrä J; Lamata M; Martinez de Tejada G; Bartels R; Koch MH; Brandenburg K
Biochem Pharmacol; 2004 Oct; 68(7):1297-307. PubMed ID: 15345319
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccaride-binding peptides obtained by phage display method.
Matsumoto M; Horiuchi Y; Yamamoto A; Ochiai M; Niwa M; Takagi T; Omi H; Kobayashi T; Suzuki MM
J Microbiol Methods; 2010 Jul; 82(1):54-8. PubMed ID: 20412822
[TBL] [Abstract][Full Text] [Related]
8. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
David SA
J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin neutralizing peptides.
Jerala R; Porro M
Curr Top Med Chem; 2004; 4(11):1173-84. PubMed ID: 15279607
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptides: the LPS connection.
Giuliani A; Pirri G; Rinaldi AC
Methods Mol Biol; 2010; 618():137-54. PubMed ID: 20094863
[TBL] [Abstract][Full Text] [Related]
11. An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor.
Zhang H; Li J; Barrington RA; Liang G; Qin G; Liu DX
Biochem Biophys Res Commun; 2007 Jul; 359(2):285-91. PubMed ID: 17543887
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide.
Ghiselli R; Giacometti A; Cirioni O; Circo R; Mocchegiani F; Skerlavaj B; D'Amato G; Scalise G; Zanetti M; Saba V
Shock; 2003 Jun; 19(6):577-81. PubMed ID: 12785015
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy.
Bhunia A; Mohanram H; Bhattacharjya S
Biopolymers; 2009; 92(1):9-22. PubMed ID: 18844294
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for endotoxin neutralization by amphipathic peptides derived from the alpha-helical cationic core-region of NK-lysin.
Brandenburg K; Garidel P; Fukuoka S; Howe J; Koch MH; Gutsmann T; Andrä J
Biophys Chem; 2010 Aug; 150(1-3):80-7. PubMed ID: 20153101
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based treatment of sepsis.
Brandenburg K; Andrä J; Garidel P; Gutsmann T
Appl Microbiol Biotechnol; 2011 May; 90(3):799-808. PubMed ID: 21369803
[TBL] [Abstract][Full Text] [Related]
17. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
Brandenburg K; Heinbockel L; Correa W; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
[TBL] [Abstract][Full Text] [Related]
18. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
Yibin G; Jiang Z; Hong Z; Gengfa L; Liangxi W; Guo W; Yongling L
Biochem Pharmacol; 2005 Jul; 70(2):209-19. PubMed ID: 15935330
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
